Clindamycin Palmitate Hydrochloride Injection
Brand names: Clindamycin Palmitate Hydrochloride (Pediatric)
Category: Anti-Infective
FDA status: To Be Discontinued · Last FDA update: Feb 27, 2026 · First posted: Feb 27, 2026 · 1 manufacturers, 1 listed presentations
As of Feb 27, 2026, the FDA lists Clindamycin Palmitate Hydrochloride Injection as being discontinued. Of 1 manufacturer presentations, 1 Not specified.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Clindamycin Palmitate Hydrochloride, Injection, 75 mg/5 mL (NDC 53746-468-19) NDC 53746-468-19 |
Amneal Pharmaceuticals | Not specified | Discontinuation of the manufacture of the drug |
Related medications in shortage
Other Anti-Infective medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Clindamycin Palmitate Hydrochloride Injection (FDA data as of Feb 27, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Clindamycin Palmitate Hydrochloride Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/clindamycin-palmitate-hydrochloride-injection.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).